What is a potential risk associated with the use of prasugrel?

Prasugrel is an antiplatelet medication commonly used to prevent blood clots in patients with certain cardiovascular conditions. The primary mechanism of action involves inhibiting platelet aggregation, which is crucial for preventing heart attacks and strokes in at-risk patients. However, this inhibition of platelet function also leads to a heightened risk of bleeding.

When a medication reduces the blood's ability to form clots, it significantly increases the likelihood of bleeding complications. This is particularly relevant in situations such as surgical procedures or injury, where normal clotting is necessary to control bleeding. Patients on prasugrel need to be closely monitored for signs of excessive bleeding, such as unusual bruising, blood in urine or stool, or prolonged bleeding from cuts.

The other options either don't apply to the direct effects of prasugrel or do not align with its use. For example, it does not decrease the risk of clots, as that would contradict its purpose, and while it may have indirect effects on other conditions, it is not directly associated with increased risks of stroke or hypertension. Thus, it is vital for healthcare professionals and patients to be aware of the increased risk of bleeding associated with prasugrel to manage this potential complication effectively.